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Abstract. We cloned a new member of the murine 
brain kinesin superfamily, KIF3B, and found that its 
amino acid sequence is highly homologous but not 
identical to KIF3A, which we previously cloned and 
named KIF3 (47% identical). KIF3B is localized in var- 
ious organ tissues and developing neurons of mice and 
accumulates with anterogradely moving membranous 
organelles after ligation of nerve axons. Immunoprecip- 
itation assay of the brain revealed that KIF3B forms a 
complex with KIF3A and three other high molecular 
weight (~100 kD)-associated polypeptides, called the 
kinesin superfamily-associated protein 3 (KAP3). In 
vitro reconstruction using baculovirus expression sys- 
tems showed that KIF3A and KIF3B directly bind with 
each other in the absence of KAP3. The recombinant 
KIF3A/B complex (~50-nm rod with two globular 
heads and a single globular tail) demonstrated plus 
end-directed microtubule sliding activity in vitro. In ad- 
dition, we showed that KIF3B itself has motor activity 
in vitro, by making a complex of wild-type KIF3B and a 
chimeric motor protein (KIF3B head and KIF3A rod 
tail). Subcellular fractionation of mouse brain homoge- 
nates showed a considerable amount of the native KIF3 
complex to be associated with membrane fractions 
other than synaptic vesicles. Immunoprecipitation by 
anti-KIF3B antibody-conjugated beads and its electron 
microscopic study also revealed that KIF3 is associated 
with membranous organelles. Moreover, we found that 
the composition of KAP3 is different in the brain and 
testis. Our findings suggest that KIF3B forms a het- 
erodimer with KIF3A and functions as a new microtu- 
bule-based anterograde translocator for membranous 
organelles, and that KAP3 may determine functional 
diversity of the KIF3 complex in various kinds of cells 
in vivo. 
mature neuronal cell has  a  polarized morphology 
comprised of dendrites, a long axon, and synapses. 
Most  of the  proteins  in  the  axon  and  synapses 
must be transported from the cell body along the axon be- 
cause it lacks protein synthesis machinery. Various kinds 
of proteins are bidirectionally transported by fast and slow 
axonal flow, and fast transport is primarily responsible for 
moving the membranous organelles. Kinesin is a microtu- 
bule-activated ATPase  (Brady,  1985;  Vale  et al.,  1985a; 
Scholey et al., 1985) that moves to the plus end of microtu- 
bules (Vale et al.,  1985b;  Saxton et al.,  1988). Since this 
protein was shown to be associated with membranous or- 
ganelles anterogradely moving in the axon (Hirokawa et 
al., 1991), it is therefore considered a leading candidate to 
be the anterograde motor. EM studies  on axons in vivo 
have shown that cross-bridge structures exist between the 
membranous organelles and microtubules, which are con- 
sistent in size and shape with the single-molecule structure 
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of kinesin (Hirokawa et al., 1989). On the other hand, we 
also identified several distinct cross-bridge structures that 
are also candidates to be membranous organelle motors 
(Hirokawa,  1982;  Hirokawa  and  Yorifuji,  1986).  Obvi- 
ously, then, a possibility exists that a number of different 
motor proteins are engaged in fast axonal transports. 
Many kinds of kinesin-like motor proteins have recently 
been  found  and  cloned  (for  review  see  Endow,  1991; 
Goldstein, 1991; Hirokawa, 1993), and all members share 
a homologous domain having ~350 amino acids and con- 
taining a site for putative ATP binding and one for micro- 
tubule binding. This superfamily of kinesin-like microtu- 
bule-based  motor  proteins  is  thought  to  have  diverse 
motility functions such as mitosis and meiosis. To identify 
new molecular motors for organelle transport, we have al- 
ready  cloned  five  members  of the  kinesin  superfamily 
(KIF1-5) from murine brain (Aizawa et al., 1992). In the 
previous study, we showed that KIF3A  (formerly desig- 
nated KIF3) is predominantly expressed in the brain and is 
a new motor protein for anterograde fast axonal transport 
(Kondo et al., 1994). 
In this study we have cloned a new member of the kine- 
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(Aizawa et al., 1992), and subsequent sequencing revealed 
that it is homologous but distinct from KIF3A. Chlonolog- 
ical and spatial expression pattern of this new motor pro- 
tein, KIF3B, was closely related with KIF3A, which leads 
to speculation that KIF3A and KIF3B are associated with 
each other. Then we found that KIF3A, KIF3B, and their 
associated proteins make a complex in vivo by immuno- 
precipitation. Detailed investigations of the KIF3 complex 
were carried out using  molecular biological, immunocy- 
tochemical, and biochemical approaches, that is, EM of its 
molecular structure and a microtubule sliding assay were 
performed using a baculovirus-expressed KIF3A/B com- 
plex, while its accumulation was examined by ligating pe- 
ripheral nerves. Taken together, our findings suggest that 
the  KIF3  complex is  another  microtubule-based  motor 
protein that participates in anterograde fast axonal trans- 
port for membranous organelles in neurons. In addition, 
we demonstrate that this complex is a heterodimeric mo- 
tor protein having associated proteins in mammalian cells. 
We named these associated proteins kinesin superfamily- 
associated protein 3 (KAP3)J 
Materials and Methods 
Cloning of KIF3B 
Construction of the kgtl0 library from poly(A) RNA of 0-d-old murine 
brains and PCR to amplify the conserved segment of cDNAs of kinesin 
superfamily members was performed, as previously described. (Aizawa et 
al., 1992; Nakata et al., 1993).  A  PCR fragment of KIF3B was used as a 
probe to screen the cDNA library according to the standard method, and 
a  full-length of KIF3B cDNA was sequenced by the dideoxynucleotide 
chain termination method. 
Northern Blot Analysis 
Total RNA was prepared, as described previously (Aizawa et al., 1992). 
mRNA  was  purified  from  total  RNA  using  Oligotex-dT30<super> 
(Takara, Kyoto, Japan). The amount of mRNA was determined by mea- 
suring the absorbance at 260 nm and adjusted by preliminary Northern 
blot  analysis using the radioactivity from a  13-actin probe.  The mRNA 
sample (1-2 txg) was electrophoresed and transferred to a nylon filter, and 
hybridization  was  performed,  as  described  previously  (Aizawa  et  al., 
1992).  For hybridization probes to detect mRNA of KIF3A and KIF3B, 
we respectively used the HincfI/PstI cDNA fragment of KIF3A (1,024 bp) 
and the EcoRI/BamHI cDNA fragment of KIF3B (1,101 bp). 
Construction of Transfer Vector and Purification of 
Recombinant KIF3B 
A  transfer vector was constructed using the pBacPAK8 transfer vector 
(BacPAK Baculovirus expression system; Clonetech Inc., Palo Alto, CA). 
To generate pBacPAKS/KIF3B containing the polyhistidine tag, we used 
the PCR method with Taq polymerase to introduce in-frame six histidine 
codons and a stop codon in the COOH terminus, pBacPAK8/KIF3B was 
finally used for transfection to obtain recombinant baculovirus containing 
KIF3B cDNA. 
The methods of transfection and selection of recombinant KIF3B virus 
were as described previously (Kondo et al., 1994).  Infected cells were re- 
suspended in binding buffer (10 mM imidazole, 0.5 M  NaC1, 20 mM Tris 
HC1,  pH 7.9) supplemented with protease inhibitor mixtures. The cells 
were then lysed with a glass-teflon homogenizer and clarified by ultracen- 
trifugation (Beckman TL100) at 100,000 g for 30 rain. The resultant super- 
natant was purified using a  chelating Sepharose FF column (nickel col- 
1. Abbreviations  used in this paper: F, fraction; KAP3, kinesin superfam- 
ily-associated protein 3; L, lysate; P, pellet; S, supernatant. 
umn) (Pharmacia Inc., Piscataway, N J)  according to the manufacturer's 
instructions. KIF3B was subsequently eluted with the elution buffer (1 M 
imidazole, 0.5 M NaC1, 20 mM Tris-HC1, pH 7.9). Typically, 0.4 mg of pro- 
tein with >95 % purity was obtained from 108 cells. 
Antibody Preparation and Affinity Purification 
To  produce  an  antibody  against  KIF3B,  the  recombinant  full-length 
KIF3B protein was used. Purified KIF3B was injected into rabbits four 
times and the rabbits were bled. The serum was then affinity purified us- 
ing a KIF3B-bound activated Thiol-Sepharose 4B affinity column (Phar- 
macia Inc.). Western blotting of the final antibodies was carried out to 
confirm no cross-reaction with KIF3A. For the motility inhibition assay, 
purified antibodies were dialyzed against a PEM buffer (0.1 M Pipes, pH 
6.8, 1 mM EGTA, i  mM MgC12). 
Western Blot Analysis 
Various mouse tissues (0.1  mg each) were homogenized into 400 ~l of 
sample buffer and boiled for 3 rain. Crude homogenates (5 ~l each) were 
fractionated on SDS-PAGE and transferred to an immobilon membrane 
(Millipore  Corp., Bedford, MA). The filters were used for the Western 
blotting as described previously (Kondo et al., 1994). The bound antibody 
was detected with 125I-labeled protein A. 
Immunofluorescence Microscopy 
The cerebrum, cerebellum, and hippocampus of 8-wk-old mice were pro- 
cessed for  immunofluorescence microscopy using affinity-purified anti- 
KIF3B antibody as described previously (Kondo et al., 1994).  Preimmune 
rabbit IgG was used for the first antibody as a control. The tissues were in- 
cubated with diluted primary antibodies (4 p.g/ml),  and then incubated 
with  rhodamine-conjugated goat  anti-rabbit  immunoglobulins (Cappel 
Laboratories, Cochranville, PA). After the coverslips were mounted, they 
were observed with a confocal laser scanning microscope (model LSM410; 
Carl Zeiss, Inc., Thornwood, NY). 
Primary neuron cultures were prepared from hippocampi of 18-d-old 
fetal  rats as  described by  Banker  and Cowan  (1977)  and  Niclas et  al. 
(1994), with a  slight modification. The cultured neurons were processed 
for immunofluorescence microscopy, as described previously (Kondo et 
al., 1994). 
Ligation of Mouse Peripheral Nerves 
Sciatic nerves of anesthetized 4-wk-old mice were tightly ligated under an- 
esthesia. After 6 h, the mice were transcardially perfused with fixative as 
described previously (Hirokawa et al., 1990).  Small pieces of nerves, both 
proximal and distal to the ligated portions, were frozen and sectioned on a 
cryostat (4-5 ~tm). Sections were stained using anti-KIF3B antibody (4 Ixg/ 
ml) and rhodamine-labeled secondary antibody. Sections from proximal 
and distal regions were treated similarly and photographed with a fluores- 
cence microscope (Axiophot; Carl  Zeiss, Inc.)  and printed  at the same 
condition. 
Immunoprecipitation 
Brains (cerebrum) or testes of 8-wk-old male mice were homogenized by 
a teflon homogenizer in 10 vol of TBS (containing 1 mM EDTA and pro- 
tease inhibitor mixtures). The homogenates were centrifuged at 800 g for 
10 min. The supernatant was collected  and NP-40  (final concentration 
1%) was added. After incubation at 4°C for 30 min, the samples were cen- 
trifuged at 10,000 g for 30 min. To reduce the nonspecific binding, protein 
A-Sepharose (Pharmacia Inc.)  was preincubated with the samples and 
centrifuged. Afterwards, affinity antibody (final 1 ixg/ml of sample) was 
added to the supernatant, and the samples were incubated at 4°C for 1 h. 
Preimmune rabbit IgG was used as a control. The immunocomplexes  were 
subsequently recovered on protein A-Sepharose at 4°C for 1 h. The im- 
munocomplex-loaded beads were  washed with  TBS  containing EDTA 
and protease inhibitors. Immunocomplexes were eluted with SDS sample 
buffer and analyzed by SDS-PAGE and silver staining. In addition, the 
SDS-PAGE gels were transferred to immobilon membrane, and Western 
blotting was performed. 
In Vitro Reconstruction of the KIF3A/B Complex 
To obtain the KIF3A/B complex, coinfection of both recombinant bacu- 
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recombinant KIF3A virus (Kondo et al., 1994) does not contain the poly- 
histidine tag. Sf9 cells were infected with both viruses at ~5 multiplicity of 
infection. About 60 h  later, ceils were harvested, homogenized in Tris- 
HC! buffer (50 mM, pH 7.5), and centrifuged at 100,000 g for 45 min. The 
supernatant was added  to  1/8  vol of 8x  binding buffer, applied  to the 
chelating Sepharose FF column, and eluted in PEM buffer containing 50 
mM of EDTA. As a  control, the same procedure was performed using 
only KIF3A virus. The samples were subjected to 7.5% SDS-PAGE gels, 
and the resultant gel was stained with Coomassie brilliant blue. The sam- 
ple obtained by this procedure was used for EM and the in vitro motility 
assay. The molar ratio of KIF3A and KIF3B was measured by densitome- 
try (model CS9000;  Shimazu, Kyoto, Japan). 
Low-Angle Rotary-shadowing EM 
The  purified  KIF3A/B  complex  solutions  (final  protein  concentration 
0.025  mg/ml) were processeed for rotary-shadowing EM, as described by 
Hirokawa et al. (1989). 
In Vitro  Motility Assay and Antibody Inhibition Assay 
of the KIF3A/B Complex 
The motility assay was performed using recombinant KIF3A/B (0.2 mg/ 
ml) as described previously (Vale et al., 1985b;  Kondo et aL, 1994).  Salt- 
extracted  Chlamydomonas  axonemes (at  an appropriate  concentration) 
(Paschal and Valee, 1993) were also used to determine the motility direc- 
tion produced by KIF3A/B. 
To perform antibody inhibition of the motility of the KIF3A/B com- 
plex, various concentrations of affinity-purified antibody against KIF3B 
were added after incubation of KIF3A/B on coverslips. After this, taxol 
(supplied by Dr. N. R. Lomax, National Cancer Institute), ATP, and mi- 
crotubules  were  applied,  and  the  movement of microtubules was  ob- 
served. 
Construction of the Chimeric Proteins 
and Truncated KIF3 
We have made the following four mutant KIF3 constructs for baculovirus 
expression. The plasmids pBS-chimera 1 and pBS-chimera 2 were con- 
structed in pBluescript II SK(+). To generate the pBS-chimera 1 or 2, we 
used the PCR method with Pfu DNA polymerase (Stratagene  Inc., La 
Jolla, CA). Chimera 1 consists of 1-308 amino acid residues of KIF3B and 
314-701 of KIF3A. Chimera 2 consists of 1-359 of KIF3B and 365-701 of 
KIF3A. The inserts were introduced into pBacPAKS. 
To make a construct that expresses a headless 3A protein (short 3A), 
the full length of KIF3A plasmid was digested with PstI and EcoRI, and 
then the fragment of rod and tail region (nucleic acid 919-2,159) was intro- 
duced  into  pBacPAK8  to  generate  pBacPAK8/short  3A.  Truncated 
KIF3B  (amino  acid  1-357),  which  contains only  the  head  domain  of 
KIF3B, was made by EcoRI digestion of full-length KIF3B and was added 
to the polyhistidine tag. Transfection and selection of recombinant viruses 
were performed as described before. 
Chimera 1, chimera 2, and short 3A virus, all of which do not contain 
the polyhistidine tag, were then coinfected with K1F3B virus containing 
the polyhistidine tag. 3 d later, the cells were harvested. The proteins were 
extracted in binding buffer and purified by chelating Sepharose FF col- 
umn. Purified proteins were used for in vitro motility assay as described 
above. 
SubceUular Fractionation of the KIF3 Complex 
40 samples of murine brain tissue (cerebrums of 7-8-wk postnatal mice) 
were used for suhcellular fractionation as described by Kondo et a1.(1994). 
In this procedure, the low- (P1), medium- (P2), and high- (P3) speed pel- 
lets and supernatant sample ($1, $2, and $3) were obtained. The effect of 
salt extraction was examined by homogenizing the P2 and P3  fractions 
with 0.5 M  NaCl in 0.32 M  sucrose buffer. These salt-extracted homoge- 
hates  were  centrifuged  at  the  same  speeds,  and  the  resultant  pellets 
(washed  P2  [wP2]  and  washed  P3  [wP3])  were  analyzed  by  immuno- 
blotting. P1-P3, $1-$3, and wP2/wP3 (30 txg each) were subjected to elec- 
trophoresis and transferred to an immobilon membrane. Fractions were 
analyzed by  immunoblotting with three  kinds of polyclonal  antibodies 
(anti-KIF3A, anti-KIF3B, or anti-P38). The antibody against P3g was ob- 
tained using the following polypeptide as an antigen: SDVKMATDPENI- 
IKG,  corresponding to  rat  P38,  amino acids  160--174  (Johnston et  al., 
1989).  The relative amount of KIF3A or KIF3B in P2, P3, wP2, and wP3 
was estimated by densitometry as described previously. 
Further fractionation was performed to obtain the synaptic vesicle frac- 
tion. P2 was washed once in sucrose buffer and centrifuged at the same 
speed (P2'), and then this 1?2' fraction was resuspended in 9 vol of ice-cold 
water.  After homogenization, the resulting 192  '  lysate (L) was added to 
Hepes-NaOH buffer (pH 7.2) (final concentration 7.5 mM) and incubated 
on ice for 30 min. Next, it was centrifuged for 20 min at 25,000 g to yield a 
lysate pellet (LP1) and a lysate supernatant (LS1). LS1 was collected and 
centrifuged for 2 h at 165,000 g, giving another lysate pellet (LP2) and su- 
pernatant (LS2). Subsequently, LP2 was resuspended in a total of 5 ml of 
50 mM sucrose. To augment the resuspension process, the suspension was 
homogenized by a glass-teflon homogenizer and passed through 25- and 
27-gauge needles attached to a syringe. The suspension was centrifuged at 
64,700 g for 2 h on a discontinuous sucrose density gradient to give seven 
synaptic vesicle fractions. Synaptic vesicle fraction 1 (F1) was supernatant, 
fraction 3 (F3) was in 0.4 M sucrose, fraction 5 (F5) was in 0.6 M sucrose, 
and fraction 7 (F7) was a pellet. F2, F4, and F6 scarcely contained any ma- 
terial. The synaptic vesicles were most abundant in F3. P2', LP1, LP2, F1, 
F3,  and F7  were  added  to NP-40, and their protein concentration was 
measured by the BCA method. These samples (30 ~g each) were immu- 
noblotted with the anti-KIF3B and anti-P38 antibodies. 
Isolation of  Axonally Transported 
OrganeUes from Cauda Equina and Immunoisolation 
of Membrane-associated KIF3A/B 
Axonally transported organelles in cauda equina were collected by the 
method described previously (Okada et al., 1995a,b). The fraction of these 
organelles ($2) was used for immunoisolation. Antibody against KIF3B 
was absorbed on protein A-Sepharose FF (Pharmacia Inc.), and was co- 
valently cross-linked by dimethylpimelimidate. $2 was incubated with the 
beads, and the beads were recovered by centrifugation and washed with 
internal medium. Preimmune rabbit lgG was used for control studies. The 
beads were  processed for conventional EM  and observed as described 
previously (Noda et al., 1995). 
Gel Filtration Assay 
The molecular size of the native KIF3 complex and recombinant KIF3A/B 
were estimated by gel filtration on a Superose 6 column (Pharmacia Inc.), 
followed by subsequent immunoblotting with the antibody against KIF3A 
and KIF3B. Brain or testes of 9-wk-old male mice were homogenized in 3 
vol of TBS (containing 1 mM EDTA and protease inhibitors). The homog- 
enates were centrifuged at 800 g for 10 min. The supernatant was collected 
and NP-40 (final concentration 1%) was added. After incubation at 4°C 
for 30 min, 1 ml of samples was centrifuged at 100,000 g for 45 min and 
loaded on the column. Purified recombinant KIF3A/B (g0 txg) was also 
centrifuged at the same speed and loaded. The fractions were then col- 
lected, and Western blotting was performed to determine the peak frac- 
tion. Calibration was performed with standard proteins (gel filtration cali- 
bration kit; Pharmacia Inc.) according to the manufacturer's instructions. 
Results 
Primary Structure of  KIF3B Revealed a Great 
Similarity with KIF3A 
We previously reported five new members of the kinesin 
superfamily found in the  murine central nervous system 
(Aizawa et al.,  1992).  To find additional members in this 
superfamily, PCR was performed using degenerate prim- 
ers  corresponding to  the  ATP- and  microtubule-binding 
domains conserved in the kinesin superfamily. In this ex- 
periment, we found a new clone that was homologous to 
KIF3A (formerly designated KIF3), but not identical to it. 
Thus, we named this clone KIF3B, and renamed KIF3 as 
KIF3A. 
To examine the structure of KIF3B in detail, we screened 
KIF3B  cDNA,  obtained  from the  0-d-old  murine  brain 
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KIF3B as a probe. Nucleotide sequence analysis revealed 
the presence of a single open reading flame of 2,241 nucle- 
otides that encoded 747-amino acid residues  (Mr,  85,281; 
Fig. 1 A). According to the Chou-Fasman (Chou and Fas- 
man,  1974)  and  Robson-Garnier  (Robson  and  Suzuki, 
1976; Garnier  et al.,  1978) secondary structure prediction 
method (Mac vector DNA analysis software International 
Biotechnologies,  Inc.,  New  Haven,  CT),  KIF3B  has  an 
NH2-terminal domain (head globular domain, amino acid 
residues  1-363),  a  central  domain  (rod  c~-helix  domain, 
amino acid residues 364-592), and a  COOH-terminal do- 
main (tail globular domain, amino acid residues  593-747) 
(Fig.  1  C).  A  diagonal  dot matrix  comparison of KIF3A 
and KIF3B showed high similarity exists  in the  head do- 
main (including motor domain)  and the latter half of the 
rod domain (Fig.  1 B). Among all the murine kinesin  su- 
perfamily  proteins  sequenced  thus  far,  KIF3B  has  the 
highest  identity with  KIF3A (47%  in  overall  length  and 
69%  in  the  motor  domain;  amino  acid  residues  from 
IFAFGQT to VDLAGSE). 
Northern blot analysis was performed to compare their 
respective  expression  in  developing neurons  and various 
tissues  (Fig.  2 A). We used  the  rod domain  cDNA frag- 
ments as probes, and neither probe showed cross-hybrid- 
ization. The KIF3B transcript is a  single band of 5.5 kbp, 
whereas KIF3A has transcripts of 5.3, 4.0, and 2.5 kbp. To 
examine their expression in developing neurons, we used 
Figure  1.  (A)  Amino  acid  sequences  (single-letter  code)  of 
KIF3B. The putative  ATP-binding site  in the motor domain is 
underlined.  These sequence data are available from GenBank/ 
EMBL/DDBJ  Data  Library  under  accession number  D26077. 
(B) Sequence comparison between KIF3A and KIF3B. Diagonal 
dot matrix  comparisons were  performed  on  MacVector DNA 
analysis software using a window size of 8 and stringency of 60%. 
AA, amino acid.  (C) Diagram showing the secondary structure 
predictions of KIF3A and KIF3B. Predictions were performed by 
the Chou-Fasman and Robson-Gamier methods using the above 
software. 
Figure 2.  (A) Northern blot analysis  of the KIF3A and KIF3B 
transcripts  (upper panels, KIF3B; lower panels, KIF3A). (Left) 
KIF3A and KIF3B expression in different mouse tissues.  Abun- 
dant transcripts of KIF3A and KIF3B can be seen in brain and 
kidney tissues.  Samples (~1  ~g) of mRNA from various tissues 
were loaded: brain (lane 1), liver  (lane 2), kidney (lane 3), lung 
(lane 4), spleen (lane 5), heart (lane 6). (Right) Developmental 
profiles of KIF3A and  KIF3B expression.  The expression pat- 
terns  showed slight  differences  between  them.  mRNA  (2  Ixg) 
from embryo and postnatal mouse brains was loaded and electro- 
phoresed. E, embryo age in days; D, postnatal age in days.  (B) 
Western  blot  analysis  of KIF3B.  (Upper panel)  Expression  of 
KIF3B in various tissues.  Samples were crude extracts (1  I~1 on 
each lane) of tissues from 8-wk-old mice. The antibody only rec- 
ognizes KIF3B,  and  no  cross-reactions  are  present.  Cerebrum 
(lane  1),  spleen  (lane 2),  liver  (lane 3),  kidney (lane 4),  heart 
(lane 5),  lung (lane 6),  small  intestine  (lane  7), testis  (lane 8), 
ovary (lane 9), pancreas (lane 10), adrenal gland (lane 11), thy- 
mus (lane 12), and skeletal muscle (lane 13). Molecular weights 
are as indicated.  KIF3B is strongly expressed  in cerebrum and 
testis.  (Lower panel)  Expression  of KIF3B in developing neu- 
rons. No change is apparent in expression of KIF3B. Age of post- 
natal mice is indicated in days (D) above each lane. 
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mals  at  days 0,  5,  14,  and  28.  Results  indicate  that  the 
amount  of expression of transcripts  did  not  significantly 
change  during  development,  although  their  expression 
patterns showed a slight difference at day 28. Distribution 
of KIF3A and KIF3B mRNA in brain, liver, kidney, lung, 
spleen, and heart tissues of day 14 mice showed both tran- 
scripts to be highly expressed in the brain and kidney, but 
only weakly expressed in the other tissues. Note that the 
expression patterns of KIF3A and KIF3B show a distinct 
resemblance. 
Recombinant KIF3B Can Be Purified by the 
Polyhistidine Tag Method 
To characterize the properties of KIF3B, we expressed it 
using the baculovirus-Sf9 expression system described by 
O'Reilly et al. (1992). Purification of the resultant recom- 
binant KIF3B protein expressed in the Sf9 cells was car- 
ried  out  by constructing  a  modified  KIF3B  cDNA  that 
includes  a  polyhistidine tag in the  COOH terminus.  Re- 
combinant  KIF3B  protein  was  purified  by  a  chelating 
Sepharose  FF  column  (nickel  column).  Approximately 
90%  of the  KIF3B protein was found to be soluble  at a 
high salt concentration  (binding buffer or elution buffer; 
see  Materials  and  Methods)  having  a  purity  >95%, 
whereas it was not recovered in soluble fractions when the 
cells were  homogenized in  a  low-salt buffer (~100  mM 
salt).  Also,  purified  KIF3B  aggregated when  it was dia- 
lyzed against buffers at physiological ionic strength. When 
recombinant KIF3B was expressed without the polyhisti- 
dine tag, a similar tendency was found (data not shown), 
thereby suggesting that KIF3B is not stable under physio- 
logical conditions. 
Using  the  purified  KIF3B  protein  as  an  antigen,  we 
raised a polyclonal antibody against KIF3B, and then af- 
finity purified it by an activated Thiol-Sepharose 4B  af- 
finity  column  (Pharmacia  Inc.).  The  resultant  antibody 
specifically reacted with the KIF3B protein (both baculo- 
virus-expressed KIF3B and mouse brain KIF3B), but did 
not cross-react with KIF3A or other KIFs (Fig. 2 B). 
KIF3B Is Associated with an Anterograde-moving 
OrganeUe That Is Transported by Fast Axonal Flow 
To investigate KIF3B's expression in tissues and develop- 
mental neurons,  and  to examine the  difference between 
KIF3A and KIF3B, we performed Western blot analysis 
on various organs of 8-wk-old mice and developing brains 
(Fig.  2  B).  The affinity-purified polyclonal antibody was 
used against KIF3B, which strongly expressed in the brain 
and testes. In the other organs, however (i.e., spleen, liver, 
kidney, lung, intestine, ovary, pancreas, adrenal gland, and 
thymus), KIF3B was only weakly expressed, while expres- 
sion in the heart and skeletal muscle was barely detected. 
Expression in various parts of the nervous system (cere- 
brum,  cerebellum, hippocampus,  spinal  cord,  and  sciatic 
nerve) was also examined, and KIF3B was most strongly 
expressed in the hippocampus and least so in the  sciatic 
nerve (data not shown). Although KIF3B's immunoreac- 
tive band was also detected as a doublet in the central ner- 
vous  system tissues,  the  upper band  was  weak  and  fre- 
quently could not be detected. The developing cerebrum 
in 3-d- to 8-wk-old mice was examined by immunoblotting, 
with KIF3B showing no remarkable change in expression 
during development. These results with KIF3B are almost 
identical to those found with KIF3A (data not shown). 
We also examined KIF3B localization in nerve tissues 
by immunofluorescence microscopy (Fig. 3 A). In the ce- 
rebrum, cerebellum, and hippocampus of 8-wk-old mice, 
anti-KIF3B  antibody strongly  stained  the  cell  bodies  of 
most neuronal cells. Axons and dendrites were also stained, 
though  somewhat  more  weakly  compared  with  the  cell 
bodies. 
To obtain more information on the subcellular distribu- 
tion of KIF3B, immunostaining was performed in cultured 
embryonic hippocampal neurons (data not shown). KIF3B 
was localized mainly in cell bodies. Axons and dendrites 
were  also  stained,  though  somewhat more weakly com- 
pared with the cell bodies. Collectively, KIF3B was mainly 
localized in neurons, fairly so in the cell bodies, and to a 
lesser degree in the axons and dendrites. 
Next, our previous studies demonstrated the presence of 
anterograde- and retrograde-moving membranous organ- 
elles  being  transported  by  fast  axonal  flow;  these  or- 
ganelles accumulate at the proximal and distal portions of 
axons, respectively, N6 h  after ligation of mouse periph- 
eral nerves (Hirokawa et al., 1990,  1991). Thus, the proxi- 
mal  and  distal  portions  of  ligated  sciatic  nerves  were 
stained  with  the  anti-KIF3B  antibody.  Immunofluores- 
cence  microscopy  subsequently  revealed  that  the  anti- 
KIF3B antibody strongly and reproducibly stained nerve 
regions proximal to the ligation. Contrastingly, staining in 
regions distal to the ligated parts was comparatively weak, 
as shown in Fig. 3 B. These results indicate that peripheral 
nerve axons contain a particular amount of KIF3B, and it 
anterogradely accumulates at a  ligation. The results with 
KIF3B  are  also  identical  to  those  found  with  KIF3A 
(Kondo et al., 1994).  We consequently believe this protein 
is strongly associated with anterograde-moving organelles 
that are transported by fast axonal flow in vivo. 
KIF3A and KIF3B Are Components of the KIF3 
Complex In Vivo 
Our results clearly indicate that KIF3A and KIF3B may 
be associated with each other; that is, they showed a simi- 
lar expression pattern in the central nervous tissues and 
other organs, Western blot analysis produced similar re- 
sults, and similarities occurred in their immunological lo- 
calization and in the peripheral nerve ligation experiment. 
To examine this possibility, we performed immunopre- 
cipitation  by  anti-KIF3A  and  anti-KIF3B  antibodies  in 
mouse brain extracts, with several bands (80/85,  95,  100- 
105 kD) being precipitated by both antibodies. The 80/85 
and 95 kD bands, respectively, correspond to the molecu- 
lar weight of KIF3A and KIF3B, and from 100 to 105 kD, 
three  bands were consistently precipitated by both anti- 
bodies  (Fig.  4  A,  lanes  1  and  2).  To  characterize  these 
bands, immunoblotting analysis was carried out on their 
gels (Fig. 4 A, lanes 4-9). In both filters, the bands at 80/85 
kD were stained by anti-KIF3A (lanes 7 and 8), and that 
at 95 kD was stained by anti-KIF3B (lanes 4 and 5). How- 
ever, the bands from 100 to 105  kD were not stained by 
these  antibodies.  These  results  indicate  that  KIF3A and 
Yamazaki et al. KIF3A/B: A Heterodimeric Microtubule-based Translocator  1391 Figure 3.  (A-C) Immunofluorescence micrographs of 8-wk-old mouse cerebrum  (A), cerebellum (B), and hippocampus (C) stained 
with anti-KIF3B antibodies. The cell bodies of neurons are strongly stained with KIF3B antibodies, while dendrites and axons show 
lower intensity. (D and E) Immunofluorescence micrographs of sections of ligated mouse sciatic nerves stained with anti-KIF3B anti- 
bodies proximal (D) and distal (E) to the ligations. The ligated portion is between these figures, 0.1 mm from each of them. Anti-KIF3B 
antibodies strongly stained the proximal portions, whereas the distal portions show less intensity. Bars, 50 ~m. 
KIF3B coprecipitated with the  anti-KIF3B antibody and 
also with the anti-KIF3A antibody, and that the three up- 
per bands may be proteins associated with both proteins. 
Taken together, KIF3A and KIF3B obviously form a com- 
plex  that  probably contains  new,  high-molecular weight 
"associated  proteins."  We  named  these  associated  pro- 
teins kinesin superfamily-associated protein 3 (KAP3). 
We also carried out the same immunoprecipitation mea- 
surements on tissue from mouse testis,  where it was found 
that KAP3 only had a single band (Fig.  4 B) vs the three 
bands in brain tissue, as well as having a different height. 
This observation suggests that composition of these associ- 
ated proteins may vary in various cell types. 
KIF3A and KIF3B Form a Heterodimer In Vitro That 
Provides Plus End--directed Motor Activity 
A  question of interest is why do KIF3A and KIF3B and 
their associated proteins form a complex in vivo. One pos- 
sibility  is  their  mutual  association,  while  another is  that 
KIF3A and KIF3B only associate with themselves. To test 
these, we performed an in vitro reconstruction experiment 
in  Sf9  cells  by  coinfecting  them  with  the  KIF3A  and 
KIF3B recombinant virus; the former virus (Kondo et al., 
1994)  has no polyhistidine tag. As controls, cells  infected 
with only KIF3A virus were also prepared and purified by 
the  same procedure.  After infection, the  cells were  har- 
vested, and the proteins were purified by the polyhistidine 
tag method. Coomassie brilliant blue staining revealed two 
bands  on  the  lane  of the  coinfected sample.  The  lower 
band was the same height as KIF3A's, the upper band was 
the  same height as KIF3B's, and the densitometry assay 
revealed  that their  molar ratio  was  about  1:1  (Fig.  5 A, 
lane  7).  We  then  used  immunoblotting  to  confirm that 
both bands were KIF3A and KIF3B (Fig. 5 B, lanes 2 and 
4).  In the cells  infected with KIF3A virus alone, the  ex- 
pression  of KIF3A was  seen  in  the  crude  homogenate 
(lane 2), but no protein was purified by this method (lane 
5), that is, the method enabled KIF3A to be copurified us- 
ing the Sf9 cells  coinfected with KIF3A and the KIF3B- 
polyhistidine tag virus.  Based  on these  results,  recombi- 
nant KIF3A and KIF3B directly form a complex in vitro; 
hence the presence of the associated proteins is probably 
not essential in forming this complex. 
The molecular structure  of the  recombinant KIF3A/B 
complex was analyzed by low-angle rotary-shadowing EM 
(Fig.  6).  Because  purification  with  the  polyhistidine  tag 
method recovers KIF3B monomer and the KIF3A/B com- 
plex, we purified the complex by taking advantage of the 
fact that the monomer aggregates in a low-salt buffer. Ex- 
traction of coinfected Sf9  cells  with this buffer separates 
the  complex as  a  supernatant  from the  monomer aggre- 
gates.  KIF3A/B in the supernatant was then highly purified 
using  the  polyhistidine  tag  (Fig.  5 A).  The  rotary-shad- 
owed complex exhibited a number of consistent morpho- 
logical features with the heterodimerization of KIF3A and 
KIF3B. For instance,  most of the  molecules had  a  rod- 
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mouse brain extracts. Lanes 1-3 show silver staining of immuno- 
precipitates in  SDS-PAGE  gel:  immunoprecipitation by  anti- 
KIF3A antibody (lane 1);  immunoprecipitation by anti-KIF3B 
antibody (lane 2); control preimmune rabbit IgG (lane 3); West- 
ern blotting of the gel of lanes 1-3 (lanes 4--9); anti-KIF3B anti- 
body staining (lanes 4-6); anti-KIF3A  antibody staining (lanes 7-9). 
In  addition  to  the  immunoglobulin  bands  (~40  kD),  several 
bands were consistently observed (lanes 1 and 2). The 80/85-kD 
band is KIF3A (lanes 7 and 8) and that of 95 kD is KIF3B (lanes 
4  and 5). Three bands of associated proteins (KAP3) (100-105 
kD) are apparent in both precipitations (lanes 1 and 2).  In the 
control lane, only immunoglobulin is present (lane 3). (B) Silver 
staining of immunoprecipitation by anti-KIF3A and anti-KIF3B 
antibody from the testis. Only a single band of KAP3 (it is almost 
the same height with the middle band in the brain) is shown in 
the testis. Lane I  shows immunoprecipitation by anti-KIF3A an- 
tibody; lane 2  shows immunoprecipitation by anti-KIF3B anti- 
body. Note that the molar ratio of KIF3A, KIF3B, and KAP3 in 
the testis was approximately 1:1:0.7. 
shaped configuration with a length of ~50 nm (48.8  --+ 3.1 
nm, n  =  120). One end of the molecule typically displayed 
two globular structures, referred to as the head  (long di- 
ameter of head 10.4 _+  1.0 nm, n  =  60), while a small glob- 
ular structure was located at the tail end of the molecule. 
The  head  and  tail regions were  connected  by a  straight, 
short shaft. In comparison with bovine brain kinesin (Hiro- 
*kawa  et  al.,  1989),  the  KIF3A/B  complex  has  a  similar 
head  domain  structure  with  a  short  rod domain.  KIF3A 
has nearly the same length and long diameter of head as 
KIF3A/B, but in contrast, it usually has a single head and a 
thin rod region (Kondo et al., 1994).  These findings sug- 
gest that KIF3A and KIF3B form a heterodimer consisting 
of a single molecule of KIF3A and KIF3B. 
Next,  to  confirm  that  the  complex  is  a  microtubule- 
based motor protein, we performed an in vitro motility as- 
say of microtubules and Chlamydomonas  axonemes (Fig. 
7). We performed an in vitro motility assay using the puri- 
fied KIF3A/B complex. It showed plus end-directed mo- 
tor activity, induced microtubule motility at ~0.3 txm/s (n = 
20),  and  moved  all of the  axonemes  toward  their minus 
ends (n =  69) at almost the same velocity. 
Since we did not purify KIF3A/B using usual procedures 
for  purifying  motor  proteins,  for  example,  nucleotide- 
dependent microtubule binding, its transport activity is al- 
Figure 5.  In vitro reconstruction of the KIF3A/B complex. (A) 
Coomassie brilliant blue staining of the gel. Lane 1 shows 8-wk- 
old mouse brain homogenates. Lanes 2-4 show crude extracts of 
baculovirus-expressed Sf9 cell proteins. Lane 2 shows infection 
with  KIF3A  recombinant  virus;  lane  3  shows  infection  with 
KIF3B recombinant virus; and lane 4 shows coinfection with re- 
combinant KIF3A and KIF3B viruses. Lanes 5-7 show proteins 
purified by the polyhistidine tag method from Sf9 cells infected 
with KIF3A virus (lane 5), KIF3B virus (lane 6), or KIF3A/B vi- 
rus (lane 7). Lane 8 shows control KIF3A purified by the micro- 
tubule-binding method (Kondo et al., 1994). KIF3A was not pu- 
rified by the polyhistidine tag method using homogenates of Sf9 
cells expressing only KIF3A because recombinant KIF3A does 
not contain this tag (lane 5).  However, KIF3A was copurified 
from the homogenates of Sf9 ceils coinfected with the KIF3A 
and the KIF3B-polyhistidine tag virus by the polyhistidine tag 
method (lane 7). Lefthand lane is the molecular weight marker. 
(B) Western blot analysis of 8-wk-old mice brain homogenates 
and purified baculovirus-expressed KIF3A/B complex. Lanes 1 
and  3  show  brain homogenates;  lanes 2  and  4  show  purified 
KIF3A/B complex; lanes I  and 2 show staining with anti-KIF3B 
antibody; and lanes 3 and 4 show staining with anti-KIF3A anti- 
body. The  molecular weight of recombinant KIF3A coincides 
with the 85-kD band of native KIF3A. 
most  surely not  due  to  low-level contamination  with  an 
unknown  motor protein. To further eliminate this limited 
possibility, as well as to investigate the effect of the anti- 
KIF3B  antibody  on  the  motility  of  KIF3A/B,  we  per- 
formed an antibody inhibition assay for microtubule mo- 
tility (Fig. 8). We used preimmune rabbit IgG as a control, 
and motility was not subsequently affected by it. We found 
that  as the concentration of the  anti-KIF3B antibody in- 
creased, a  decrease occurred in: (a) the number of micro- 
tubules that were attached to the glass surface; and (b) the 
proportion  of  moving  microtubules  (Table  I).  Interest- 
ingly, the velocity of microtubules decreased as the con- 
centration  of the  antibody increased,  until  at  0.2  mg/ml, 
microtubules on the glass were scarcely seen,  and  all the 
microtubules  attached  to  the  glass  remained  stationary. 
These  results  indicate  that  the  KIF3A/B  complex  pos- 
sesses motor activity and that an antibody against KIF3B 
Table L Antibody Inhibition Assay of KIF3A/B Complex 
Motility in Vivo 
Antibody concentration 
(mg/ml)  0  0.005  0.017  0.05 0.2  Normal IgG 
Motility (%)*  100  80  70  55  0  100 
*  The motility  of microtubules  was determined  by the ratio  of motile  microtubules  to 
total microtubules  bound on coverslips.  At each  concentration,  20 microtubules  were 
examined. 
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ing electronmicrographs of recombi- 
nant KIF3A/B complex. Single mole- 
cule  of  the  recombinant  KIF3A/B 
complex. Several representative mol- 
ecules are indicated.  Arrowheads in- 
dicate the heads. Note the number of 
heads  (arrowheads). In  the  tail  do- 
main  of KIF3A/B,  a  small  globular 
structure appears. Bar, 50 nm. 
affects KIF3A/B by blocking microtubule sliding and mi- 
crotubule-binding activity. 
KIF3B Head Has Motor Activity as Well as KIF3A 
In  the  present  study,  we  showed  that  KIF3A/B  het- 
erodimer also has motor activity in vitro. We have already 
shown that KIF3A itself is sufficient for supporting micro- 
tubule motility in vitro (Kondo et al., 1994).  Then a ques- 
tion arises whether KIF3B itself is sufficient to induce mi- 
crotubule motility or if it only modifies the motor activity 
of KIF3A. We have tried the in vitro motility assay using a 
full length of KIF3B. Although several experiments were 
performed in  various  conditions,  we  could  not  show  its 
motility because of aggregation. A  truncated KIF3B con- 
struct (amino acid 1-357) was made and expressed by the 
baculovirus system, but it also aggregated in the same con- 
ditions. To overcome this problem, we tried to take advan- 
tage of the fact that KIF3B is solubilized by making a com- 
plex with KIF3A in the  rod-tail domain. We designed  a 
protein complex that has two KIF3B heads by replacing a 
head  domain  of KIF3A to  that  of KIF3B,  or  a  protein 
complex that has only one motor domain by deleting the 
head domain of KIF3A, leaving the KIF3B polypeptide in- 
tact. In either case, if microtubule motility is shown, then 
the KIF3B head domain is proven to have motor activity, 
because  the  KIF3A head  is  not  included  in  these  com- 
plexes. For this purpose, we constructed three altered vi- 
rus vectors (chimera 1, chimera 2, and short 3A) by PCR, 
and  each  of  them  was  coinfected  with  a  full  length  of 
KIF3B virus containing  the  polyhistidine  tag to perform 
an in vitro motility assay using microtubules or Chlamy- 
domonas  axonemes. Chimeras 1 and 2 have a KIF3B head 
(amino acid 1-308)/KIF3A rod tail (amino acid 314-701), 
and  a  KIF3B  head  (amino  acid  1-359)/KIF3A  rod  tail 
(amino  acid  365-701),  respectively.  On  the  other  hand, 
short  3A  consists  of only a  rod-tail  region  (amino  acid 
317-701).  All the proteins do not contain a  polyhistidine 
tag,  so if they  form a  complex with  each  other,  we  can 
copurify  each  altered  protein  with  KIF3B  protein  by 
nickel column. The results are shown in Fig. 9, indicating 
the complex formation and motility assay with the schema 
of constructs. Short 3A aggregated in physiological condi- 
tions so that it did not form a complex. Chimera i  and chi- 
mera 2  are soluble, and both of them formed a  complex 
with KIF3B in vitro. Interestingly, chimera 1 showed plus 
end-directed microtubule motility at ~0.3 ixm/s (n  -- 20), 
whereas we could not  show the  motility of chimera 2  in 
any  conditions  (though  it  revealed  microtubule-binding 
activity). These results indicate that the KIF3B head itself 
can  reveal  motor  activity  even  if  its  rod-tail  region  is 
KIF3A's. Furthermore, the structural difference between 
chimera  1  and  chimera  2  is  that  the  former  contains 
KIF3A's "neck," which connects head domain and rod do- 
main, and the latter has KIF3B's one. These opposite re- 
sults in motility suggest the importance of this "neck" re- 
gion to microtubule motility. 
The KIF3 Complex Associates with the 
Membranous Organelles, but Is a Putative 
Nonsynaptic Vesicle Motor In Vivo 
We  used  a  centrifugation  sedimentation  assay of mouse 
brain homogenates to analyze the subcellular localization 
of the native KIF3A/B complex with associated proteins, 
called the KIF3 complex. After low-, medium-, and high- 
speed centrifugation  (see Materials and Methods), West- 
ern blot analysis was performed on all particulate (P1-P3) 
and supernatant (S1-$3) fractions. Previous studies showed 
that the low-speed pellets (P1) contain the nuclear fraction 
and mitochondria, medium-speed pellets (P2) the synapto- 
somes and lysosomes, and high-speed pellets (P3) mostly 
microsomes (Ueda et al., 1979). Only P1 had relatively less 
of the KIF3 complex, while P2, P3, and S1-$3 showed al- 
most the same amounts (Fig. 10 A). To determine whether 
KIF3 tightly binds  to  sedimented  organelles,  P2  and  P3 
were washed and extracted with 0.5 M NaC1 in 0.32 M su- 
crose  buffer  (wP2  and  wP3).  After  this,  70--80%  of the 
complex was detached from the sedimented organelles. 
The  P2  fraction  was  further  fractionated  by  hypoos- 
motic shock and sucrose gradient centrifugation to investi- 
gate whether KIF3 binds to synaptic vesicles (Fig.  10 B). 
The  blot  was  stained  with  an  antibody  against  synaptic 
vesicle membrane protein  P38  (synaptophysin)  (Huttner 
et al., 1983), and the peak fraction of KIF3 was clearly dis- 
tinct from the peak of P38. In addition, KIF3's peak frac- 
tion  was  a  supernatant  of  the  sucrose  density  gradient 
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of  polyhistidine tag-purified 
KIF3A/B.  (Left)  Moving mi- 
crotubules taken  at 20-s inter- 
vals. Arrows indicate the tips of 
moving  microtubules.  (Right) 
Analysis of the direction of the 
movement  produced  by  re- 
combinant  KIF3A/B. Chlamy- 
domonas  axonemes  were  as- 
sayed for gliding activity, and 
they  glided toward  their  com- 
pact end, indicating plus end- 
directed  motility  activity  of 
KIF3A/B. Bar, 5 tzm. 
(F1),  while  the  peak  of P38  was in  F3  (synaptic vesicle 
fraction; see Materials and Methods). 
Thus, in subcellular components, the KIF3 complex exists 
in  ubiquitous  fractions.  We  could not  confirm, however, 
that it is abundantly present in synaptic vesicle fractions. 
Next, to confirm that KIF3 actually associates with the 
membranous organelles, membrane-associated KIF3 was 
isolated  by  immunoprecipitation  with  anti-KIF3B  anti- 
body-conjugated Sepharose beads. The rat cauda equina 
homogenates were centrifuged at low speeds. Then the su- 
pernatant  was  reacted  with  antibody-conjugated beads. 
EM showed various sizes of vesicles (90-160 nm diam) lo- 
cated on the surface of the beads (Fig. 11 A, C-E), while 
none  were  present  on preimmune  IgG-conjugated ones 
(Fig.  11 B), indicating that KIF3B immunoprecipitated in 
membrane bound form. At higher magnification, vesicles 
are mostly 90-160 nm in diameter, but multivesicular bod- 
ies were not observed. These results support the findings 
that KIF3 associates with the transported membranous or- 
ganelles in nerve axons. 
The KIF3 Complex Is a Heterotrimeric Motor In Vivo 
We measured the molecular size of the native KIF3 complex 
in the brain and the recombinant KIF3A/B complex using 
gel filtration and immunoblotting. From these experiments, 
we estimated the native relative molecular mass of KIF3 
to be ~350 kD and recombinant KIF3A/B to be ~250 kD. 
The same results were also obtained for the testis. 
Next, to determine the accurate molar ratio of each sub- 
unit of the native KIF3, we used gel densitometry of the 
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Figure 8.  Antibody-blocking assay of KIF3A/B motility. The ve- 
locity of the microtubule slows as the antibody concentration in- 
creases,  and finally  all microtubules on the cover glass remain 
stationary. Preimmune IgG showed no effect on their motility. 
lane containing KIF3A, KIF3B, and KAP3. As each sub- 
unit consists of a single band in the testis, we measured the 
immunoprecipitates of them. Silver or Coomassie brilliant 
blue staining of the gel revealed that the average molar ra- 
tio was KIF3A/KIF3B/KAP3 =  1:1:0.7. 
Taken together with our EM data, it  seems likely that 
most of the native KIF3 may be a  heterotrimeric protein 
comprised of 1 mol KIF3A (80/85 kD), 1 tool KIF3B (95 
kD), and 1 mol KAP3 (100-105 kD), with a total molecu- 
lar mass of ~300 kD.  The decrease in the molar ratio of 
KAP3 to the KIF3A/B heterodimer  suggests that a small 
fraction of KIF3A/B is free of KAP3, while the majority 
portion is associated with a KAP3 polypeptide. 
Discussion 
KIF3B Forms a Heterodimer with KIF3A 
Our immunoprecipitation  measurements  on mouse cere- 
brum by anti-KIF3A or anti-KIF3B antibodies both showed 
that  KIF3A and  KIF3B  form  a  complex with  KAP3  in 
vivo. We also proved by the in vitro reconstruction assay 
using  the  baculovirus  expression  system that  KIF3B  di- 
rectly binds to KIF3A, and that KAP3 is not essential for 
this  binding.  Moreover,  EM  analysis  revealed  that  the 
KIF3A/B complex has two globular structures  (head)  on 
one end that are connected by a short rod domain to a sin- 
gle globular structure (tail) at the other end, hence indicat- 
ing  that  KIF3A  and  KIF3B  form  a  heterodimer  at  the 
a-helical rod domain. This is further supported by our an- 
tibody  inhibition  experiment  on  the  KIF3A/B  complex. 
Antibody specific to KIF3B inhibited the microtubule mo- 
tility by the  KIF3A/B  complex in  vitro  as  shown in  the 
present  study,  while  KIF3A by itself produced  microtu- 
bule motility in vitro (Kondo et al., 1994). These findings 
suggest that  the  motor function  of the  KIF3A head  do- 
main is severely affected by the presence of the antibody 
decoration on KIF3B, which inhibits  microtubule  sliding 
and  microtubule-binding  activity.  This  antibody  decora- 
tion may either restrict the motility of the complex by pro- 
ducing resistance or cause a steric hindrance that prevents 
the KIF3A head from binding to the microtubule. 
When KIF3B's amino acid sequence was compared with 
other predicted kinesin-related proteins by the CLUSTAL 
V  computer  program  (Higgins  et  al.,  1992),  it  was  most 
similar to sea urchin KRP85K/95K (Cole et al., 1993) and 
Drosophila KLP64D/68D (Stewart et al., 1991; Pesavento 
et al., 1994; for review see Goldstein, 1993). By comparing 
the  identity  in  the  motor domain  among these  proteins, 
KIF3B  was  found  to  have  69  and  89%  identity  (amino 
acid; from IFAYGQT to VDLAGSE) with KRP85K and 
KRP95K,  respectively,  and  72  and  65%  identity  (frag- 
ment sequence  of the motor domain)  with KLP64D and 
KLP68D, respectively. On the other hand, KIF3A showed 
corresponding identities  of 84 and  70%  with  the  former 
proteins and 78 and 62% with the latter ones. Such identi- 
ties  suggest  that  KIF3A  and  KIF3B  may be  respective 
counterparts of sea urchin KRP85K and KRP95K, which 
were immunoprecipitated  from cytosol as a complex hav- 
ing a  115-kD subunit  (Cole et al.,  1993).  It is not proven 
whether KRP85K and KRP95K form a heterodimer, but if 
so, this would strongly support our findings. 
The  expression  pattern  of KIF3A and  KIF3B showed 
good agreement  in  the  protein  level of all  organ  tissues 
subjected  to Western blot analysis.  However, the  North- 
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1  head  ~e4  rod~-helix  593  tail  b  747 
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1  369  600  701 
1  AT~binding 
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complex 
formation 
with KIF3 B 
-I- 
+ 
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IIIIIIIIIIIIInlllllllllll  4- 
365  701 
$17  701 
Figure 9.  Summary of the re- 
motility  suits  from the copurification 
experiments and the in vitro 
motility  assays  of  various 
KIF3A/B  constructs.  Full- 
+  lengths of KIF3B and KIF3A 
are  shown  at  the  top.  Chi- 
"t-  mera 1, chimera 2, and short 
KIF3A are described below. 
All  of them,  except  for the 
--  full-length  KIF3B,  do  not 
contain the polyhistidine tag. 
Domain structure (head, rod 
N.A.  a-helix,  and  tail)  or  ATP- 
binding site and microtubule 
(MT)-binding  site  are  indi- 
cated by arrows. The positions where the KIF3B head and KIF3A rod-tail are connected in chimera and where KIF3A is truncated are 
also described. The numbers in each protein are the amino acid positions of KIF3A and KIF3B. Each construct was coinfected with full- 
length KIF3B containing the polyhistidine tag and purified by nickel column. Although chimeras 1 and 2 formed a complex, only chi- 
mera 1 showed microtubule motility.  Short 3A aggregated in physiological conditions and did not form a complex. NA, not applicable. 
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(A) Immunoblot of KIF3A and KIF3B in the fractions of S1-$3, 
P1-P3,  washed  P2  (wP2)  and  washed  P3  (wP3). The  same 
amount  of protein  (30  t~g) from each  fraction  was applied  to 
SDS-PAGE and  analyzed. P1  contains  a  small amount  of the 
KIF3 complex, whereas the other fractions (S1-$3, P2, and P3) 
contain  almost equal  amounts  of KIF3. wP2 and wP3 indicate 
that KIF3 tends to detach from the membrane components in a 
high-salt condition.  (B) The synaptosome  fraction from mouse 
brain was fractionated by sucrose gradient centrifugation and an- 
alyzed by immunoblotting.  Anti-P38  (synaptophysin)  antibody 
was used to detect the P38-containing vesicle fractions. Each frac- 
tion (see Materials and Methods) was stained by the anti-KIF3B 
and  anti-P38 antibodies. The peak fraction of KIF3B is clearly 
distinct from that of P38. 
ern blot analysis on developing neurons showed a  slight 
difference between the amount of expressed KIF3A and 
KIF3B mRNA at day 28, while the amount of KIF3A and 
KIF3B protein  showed good agreement in  the  develop- 
mental Western blot. This slight difference suggests that 
the expression of KIF3A and KIF3B might be regulated at 
the translation level. In fact, we observed unique charac- 
teristics of KIF3B that may explain the mechanism of this 
regulation: During the purification of recombinant KIF3B 
and the KIF3A/B complex, KIF3B was found to aggregate 
under a physiological salt condition, but no such aggrega- 
tion occurred for KIF3A/B. Since monomeric KIF3A is in- 
stead soluble under this condition, when taken together, 
these findings indicate that monomeric KIF3B may not be 
able  to  exist  in  soluble  form in  vivo. If true,  then  het- 
erodimerization with KIF3A may be essential for the sta- 
bility of KIF3B in vivo. Thus, these findings suggest that 
these characteristics of KIF3B contribute to the regulation 
of their expression. 
The KIF3 Complex Is a Microtubule-based Plus 
End--directed Axonal Motor 
Previous studies  have identified  kinesin  and cytoplasmic 
dynein as plus end- (Vale et al.,  1985a)  and minus end- 
(Paschal and Vallee, 1987) directed motors in neurons. Al- 
though both proteins are attached to axonal membranous 
organelles,  kinesin  is  preferentially  accumulated  on  the 
proximal side of a ligated nerve, while cytoplasmic dynein 
accumulates on both sides of the ligation (Hirokawa et al., 
1990,  1991).  Our results  from the  Western blot  analysis 
and  immunofluorescence  microscopy  showed  that  the 
KIF3 complex is strongly expressed in neurons.  We also 
found that  the  KIF3 complex preferentially accumulates 
on the proximal side of ligated axons, where anterogradely 
moving organelles accumulate; the motility assay of the re- 
combinant KIF3A/B complex supports this finding. 
We hypothesize that the KIF3 complex is a unique mo- 
tor protein composed of the KIF3A/B heterodimer,  and 
Figure 11.  Electron micrographs of affinity-purified KIF3B-asso- 
ciated vesicles. The surface of anti-KIF3B antibody-conjugated 
(A and C-E) or preimmune rabbit IgG-conjugated beads (B) af- 
ter being incubated with the crude membrane fraction of cauda 
equina.  At lower  magnification, membranous  organelles  were 
visible on the anti-KIF3B antibody--conjugated bead (A, arrow- 
heads), but not on the  preimmune  rabbit  IgG-conjugated one 
(B). Higher magnification (C-E) showed KIF3B-associated vesi- 
cles as relatively uniform particles with a diameter of 90-160 nm. 
Bars: (A and B) 500 nm; (C-E) 100 nm. 
that it provides another means for anterograde fast axonal 
transport. Concerning what cargo(es) KIF3 transports, the 
subcellular  fractionation  experiments  and  EM  study  of 
immunoprecipitated beads showed that it is ubiquitously 
associated with membranous organelles, but does not ac- 
cumulate in synaptic vesicle fractions containing P38. Ob- 
viously then,  this  complex is  probably not  a  motor that 
specifically  transports  the  synaptic  vesicles  themselves. 
However, a possibility nevertheless remains that it associ- 
ates with the transporting precursor of the synaptic mem- 
brane by detaching from the synaptic vesicle at nerve ter- 
minals. Because the KIF3 complex exists in various mouse 
tissues, and may possibly have close homologues with pro- 
teins  from the  sea  urchin  and Drosophila,  a  reasonable 
postulation is that it conveys membranous organelles gen- 
eral  to  various  cell  types in  vivo. This  behavior is  sup- 
ported  by the  subcellular  fractionation  data.  Future  re- 
search using appropriate markers is expected to elucidate 
which cargoes are carried by KIF3. 
KAP3 May Regulate the Functions of KIF3 in Various 
Cell Types 
The number of bands and molecular weight of KAP3 were 
different in the brain and testis.  It is thought that kinesin 
and KIFs that provide transport of membranous organelle 
have some mechanism for recognizing and binding to car- 
goes. It has  been  generally speculated  that  kinesin  light 
chains  play  such  a  role,  but  no  concrete  evidence  has 
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different in the brain vs testis may support this idea, and 
this  also  suggests  that  its  composition in  various  tissues 
may be dependent on some functional diversity related to 
transporting different cargoes. 
However, whether this phenomenon is due to a selective 
association by  a  distinct  polypeptide  of KAP3,  which is 
formed by alternative splicing or by other genes'  expres- 
sion;  a  posttranslational  modification,  e.g.,  phosphoryla- 
tion, in the same polypeptide of KAP3; or simply proteoly- 
sis of a single polypeptide of KAP3, remains uncertain. In 
the  case  of  kinesin,  a  ~64-kD  kinesin  light  chain  was 
found to be associated with kinesin heavy chains (Vale et 
al., 1985b; Bloom et al., 1988). Later, several distinct kine- 
sin light chains cDNAs were shown to be formed from al- 
ternative splicing of a single gene (Cyr et al., 1991; Gauger 
and Goldstein,  1993; Wedaman et al.,  1993).  Thus, multi- 
ple light chain proteins can provide a means for generating 
multiple functionally specialized forms of the kinesin ho- 
loenzyme.  Therefore,  various  kinds  of  KAP3  may  be 
formed by the same mechanism. This finding provides us 
with  new information that  can  be  applied  to investigate 
the association between motor proteins and their cargoes. 
The KIF3B Head Itself Has Microtubule Binding and 
Sliding Activity 
We  constructed  two  chimeric  KIF3A/B  and  truncated 
KIF3A  (short  3A)  viruses  to  coinfect  with  a  full-length 
KIF3B virus using Sf9 cells. Among these altered proteins, 
a complex with chimera 1 and KIF3B showed microtubule 
motility in vitro. These  results suggest  that  KIF3B  itself 
has motor activity  and  does  not simply modify KIF3A's 
motor activity. It is not always necessary to have heteroge- 
nous heads for this dimeric motor to generate force. Al- 
though this may not happen in vivo, there may be no dif- 
ference  between  the  functions  of  KIF3A  and  KIF3B 
heads. 
Another interesting  observation is  that  a  slight  differ- 
ence between two chimeric proteins caused opposite  re- 
suits in motility, though both of them formed a  complex 
with native KIF3B.  Chimera 1 has a KIF3B  head (amino 
acid 1-308)/KIF3A  rod tail (amino acid 314-701),  but chi- 
mera 2 has a KIF3B  head (amino acid 1-359)/KIF3A  rod 
tail (amino acid 365-701).  The difference is only the neck 
region sequence (amino acid, 3A; 314-368,  3B; 309-363), 
which  connects  the  head  and  rod  domains;  chimera  1 
showed microtubule  motility whereas  chimera 2  did  not 
show it. This implies that a proper neck region is impor- 
tant for dimerization and microtubule motility. Recently, 
some observations have suggested that the corresponding 
"neck" region of the kinesin heavy chain is important for 
protein dimerization (Huang et al., 1994), and such a neck 
region  of myosin is  important  for force  generation.  The 
KIF3A/B complex also seems to be unable to show motil- 
ity without the right  "neck"  region.  Our results strongly 
support these investigations. 
This  study  showed  that  previously  reported  KIF3A 
(Kondo et al., 1994)  is one component of the KIF3 com- 
plex,  and  this complex actually associates with membra- 
nous  organelles  in nerve  axons.  We  also revealed  some 
molecular mechanism of dimerization and motor activity 
of KIF3. The molecular structure of the native KIF3 com- 
plex, the primary structure and biochemical characteristics 
of KAP3, and the precise functions of the KIF3 complex in 
vivo are intriguing problems that need to be examined in 
the near future. 
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